Intensive Treatment With Ivermectin and Iota-Carrageenan as Pre-exposure Prophylaxis for COVID-19 in Health Care Workers From Tucuman, Argentina

Am J Ther. 2021 Aug 16;28(5):e601-e604. doi: 10.1097/MJT.0000000000001433.

Authors

Affiliations

¹ Ministry of Health, Tucumán, Argentina.
² Province Health System, SI.PRO.SA, Tucumán, Argentina.
³ Health Research Institute, Ministry of Health, Tucumán, Argentina.
⁴ Clinical Hospital "Ángel C. Padilla," Tucumán, Argentina.
⁵ Medical Center Emergence, Tucumán, Argentina.
⁶ Research and Technology Center, Mogi das Cruzes University, Brazil.
⁷ School of Medicine-Superior Institute of Biological Research (INSIBIO-CCT CONICET), Tucumán, Argentina.

No abstract available

Publication types

Letter
Randomized Controlled Trial

MeSH terms

Adult
Antiparasitic Agents / administration & dosage*
Antiparasitic Agents / therapeutic use
Antiviral Agents / administration & dosage*
Antiviral Agents / therapeutic use
Argentina
COVID-19 / prevention & control*
Carrageenan / administration & dosage*
Carrageenan / therapeutic use
Female
Health Personnel*
Humans
Ivermectin / administration & dosage*
Ivermectin / therapeutic use
Male
Pre-Exposure Prophylaxis / methods*
SARS-CoV-2
Treatment Outcome

Substances

Antiparasitic Agents
Antiviral Agents
Ivermectin
Carrageenan